| PDF (586kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-254301
- DOI to cite this document:
- 10.5283/epub.25430
Alternative links to fulltext:Pubmed
Abstract
The mixed dopamine (DA) agonist/antagonist terguride acts as a DA antagonist on normosensitive receptors but shows DA agonistic properties at supersensitive DA receptors. Such a compound could offer an alternative to the treatment of Parkinson's disease with indirect or direct DA agonists. The present study compares the actions of terguride, 4-12 mg/kg i.p., in naive common marmosets with its ...

Owner only: item control page
Download Statistics